Wintrust Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Wintrust Investments's ELV Position: Q4 2024 in Review
Wintrust Investments sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 69 shares — an estimated $36K sold.
Wintrust Investments first reported a position in ELV in Q1 2017 and held it in 22 quarters. The position peaked at $416K in Q4 2017. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.
- Wintrust Investments reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
- Wintrust Investments sold 69 Elevance Health shares in Q4 2024, an estimated $36K.
- Wintrust Investments first reported a position in Elevance Health in Q1 2017 and held it in 22 quarters.
- Wintrust Investments's Elevance Health position peaked at $416K in Q4 2017.
- 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.
Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.